Company Overview and News

 
Did Aurora Overpay For CanniMed?

2018-03-16 seekingalpha
On March 9, Aurora Cannabis (OTCQB: ACBFF) announced that it has successfully completed its acquisition of CanniMed (OTC:CMMDF). The announcement stated that 70.66% of the outstanding shares have been tendered and all other conditions have been met under the offer. Aurora also announced that it will issue a total of approximately 50.6 million Aurora common shares and pay a total of approximately $98 million in cash for the CanniMed Shares tendered as of March 8, 2018.
Upvote Downvote

 
Marijuana Stocks And Industry Drivers For 2018

2018-03-14 seekingalpha
I believe that this year we will see industry drivers related to capital raises and M&A.
Upvote Downvote

 
Could Aurora Lower Its Bid For CanniMed Too?

2018-03-08 seekingalpha
Aphria lower its cash bid for Nuuvera by 40%, prompting us to figure out whether Aurra could do the same to CanniMed?
Upvote Downvote

 
Canopy And Aurora: Who Just Had The Better Quarter?

2018-02-23 seekingalpha
Canopy announced lower cash cost, higher production and strong build in inventory which supported its recent supply deal wins.
Upvote Downvote

1
Marijuana Stocks That Could Outpace The Market In 2018

2018-02-20 seekingalpha
Private and public funds are throwing tens of million of dollars in anticipation of several industry catalysts that will be seen in 2018.
Upvote Downvote

 
Fagron: Compounding Returns In A Compounding Company

2018-02-14 seekingalpha
There are plenty of growth prospects with medicinal cannabis product distribution as icing on the cake.
Upvote Downvote

 
Aurora Cannabis: Firing On All Cylinders

2018-02-13 seekingalpha
Aurora Cannabis (OTCQX:ACBFF) reported its second quarter fiscal 2018 results last week. The cannabis industry has been in the spotlight lately as investors focus on the upcoming legalization. The current medical market is expected to expand but the recreational market represents the bulk of the eventual consumption. Aurora is currently building out its Aurora Sky facility and its pending acquisition of CanniMed (OTC:CMMDF) will further boost its production profile and customer base.
Upvote Downvote

4
The S-Curve Reveals It Is Early Days In The Marijuana Growth Cycle

2018-02-13 seekingalpha
I have been following the Marijuana sector since it began to surface as a new market in 2013. At the time I just followed Tweed Marijuana now known as Canopy Growth (OTCPK:TWMJF) because they were moving into the old Hershey factory in Smith Falls Ontario. At the time I lived not far away, it was making local news and the potential looked enormous. In hindsight we now know how enormous that potential became.
Upvote Downvote

4
Where We Are In The Cannabis Stock Market Cycle

2018-02-13 seekingalpha
The cannabis stocks are transitioning from the first stage of the bull market to the second stage. This means investors should change their portfolio strategy.
Upvote Downvote

1
Like Marijuana Post-Crash? You'll Love This Company

2018-02-05 seekingalpha
This is the second time I am writing about Village Farms International, due to the undervaluation that is still present in its price.
Upvote Downvote

1
Cannabis Stocks: Not A Dot-Com Bubble...Yet

2018-01-25 seekingalpha
The cannabis stocks have been on a tear and people are worried there is too much speculation in the market. Investors are afraid to buy and scared to sell.
Upvote Downvote

 
Aurora Cannabis Lands CanniMed: What It Gets From The Deal

2018-01-25 seekingalpha
There was a lot of hype about the cannabis market in 2017, resulting in many companies soaring far beyond their existing value, as speculators temporarily took over the narrative.
Upvote Downvote

4
Canadian Cannabis Stocks: 2018 Outlook

2018-01-03 seekingalpha
Canadian cannabis stocks had a positive year in 2017 with the Let's Toke Business Marijuana Composite posting a return of.21.7% and the LTB Licensed Producer Index recording a return of.46.0%.
Upvote Downvote

2
The BAK Portfolio: The Streets Are Paved In Green

2017-12-31 seekingalpha
I increased my exposure to the cannabis industries with the purchase of a global, online vaporizer retailer and a company providing an innovative source of funding for cannabis companies.
Upvote Downvote

5
Canadian Marijuana Stocks Have U.S. Investors Looking At F Stocks

2017-11-27 seekingalpha
For US investors, Canadian marijuana stocks may offer more opportunity while the US tries to figure out which path it wants to take for national legalization.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...